Position in GPCR
as of Jun 30, 2026
· filed Sep 2, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
14 quarters on record
Common Shares in GPCR Over Time
Shares Held
Position Value (USD)
Derivatives in GPCR
reported options exposure · as of Jun 30, 2026CallValue
$4,014,516
CallShares
74,800
PutValue
$2,908,914
PutShares
54,200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $6,150,763,744 across 435 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
1,425,517 | $406,229,578 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
3,760,028 | $280,046,885 | |
| 3 | INSM |
INSMED Inc
|
2,556,973 | $272,624,460 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
507,233 | $272,358,759 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
510,430 | $253,545,893 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,006,676 | $242,578,715 | |
| 7 | MANE |
Veradermics, Inc
|
1,877,775 | $230,853,658 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,576,261 | $197,343,876 |
All Filings in GPCR
Export CSV
34 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,908,914 | 54,200 | Put | Defined | 2026-09-02 | |
| 2026-06-30 | $4,014,516 | 74,800 | Call | Defined | 2026-09-02 | |
| 2026-03-31 | $2,896,820 | 60,100 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $2,617,260 | 54,300 | Put | Defined | 2026-05-15 | |
| 2025-12-31 | $53,728,626 | 772,518 | Shares | Defined | 2026-02-17 | |
| 2025-12-31 | $3,811,340 | 54,800 | Put | Defined | 2026-02-17 | |
| 2025-12-31 | $5,515,315 | 79,300 | Call | Defined | 2026-02-17 | |
| 2025-09-30 | $12,426,400 | 443,800 | Shares | Defined | 2025-11-14 | |
| 2025-09-30 | $2,335,200 | 83,400 | Put | Defined | 2025-11-14 | |
| 2025-09-30 | $3,082,800 | 110,100 | Call | Defined | 2025-11-14 | |
| 2025-06-30 | $1,684,088 | 81,200 | Call | Defined | 2025-08-14 | |
| 2025-06-30 | $1,847,934 | 89,100 | Put | Defined | 2025-08-14 | |
| 2025-06-30 | $27,552,653 | 1,328,479 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $773,757 | 44,700 | Call | Defined | 2025-05-15 | |
| 2025-03-31 | $2,030,463 | 117,300 | Put | Defined | 2025-05-15 | |
| 2025-03-31 | $17,177,405 | 992,340 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $4,019,184 | 148,200 | Put | Defined | 2025-02-14 | |
| 2024-12-31 | $40,119,672 | 1,479,339 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $759,360 | 28,000 | Call | Defined | 2025-02-14 | |
| 2024-09-30 | $1,992,606 | 45,400 | Call | Defined | 2024-11-14 | |
| 2024-09-30 | $2,962,575 | 67,500 | Put | Defined | 2024-11-14 | |
| 2024-09-30 | $63,706,246 | 1,451,498 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,667,818 | 93,400 | Put | Defined | 2024-08-14 | |
| 2024-06-30 | $55,307,278 | 1,408,385 | Shares | Defined | 2024-08-14 | |
| 2024-06-30 | $2,670,360 | 68,000 | Call | Defined | 2024-08-14 | |
| 2024-03-31 | $3,973,122 | 92,700 | Call | Defined | 2024-05-15 | |
| 2024-03-31 | $54,683,444 | 1,275,862 | Shares | Defined | 2024-05-15 | |
| 2024-03-31 | $2,082,996 | 48,600 | Put | Defined | 2024-05-15 | |
| 2023-12-31 | $46,995,668 | 1,152,985 | Shares | Defined | 2024-02-14 | |
| 2023-12-31 | $1,557,032 | 38,200 | Call | Defined | 2024-02-14 | |
| 2023-12-31 | $998,620 | 24,500 | Put | Defined | 2024-02-14 | |
| 2023-09-30 | $54,483,448 | 1,080,592 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $14,535,490 | 349,663 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $8,713,967 | 366,287 | Shares | Defined | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||